Combined Research Orlando Phase I-Iv is a clinical research site located in Orlando, Florida, United States 32807.
Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.
Combined Research Orlando Phase I-Iv has participated in 28 clinical trials with 12 currently active.
Therapeutic areas: Major Depressive Disorder, Depressive Disorder, Major, Immunoglobulin A Nephropathy.
Sponsors: Xenon Pharmaceuticals Inc., Naurex, Inc, an affiliate of Allergan plc, Alpine Immune Sciences Inc, A Subsidiary of Vertex.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Florida · View every site in Orlando
Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Combined Research Orlando Phase I-Iv has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Combined Research Orlando Phase I-Iv has 28 clinical trials on record, with 12 currently active. Their work covers Major Depressive Disorder, Depressive Disorder, Major, Immunoglobulin A Nephropathy.
Combined Research Orlando Phase I-Iv has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.